93 results
Page 2 of 5
424B5
2uj86rrmjv75im7xlw39
8 Nov 22
Prospectus supplement for primary offering
9:50pm
424B5
4o3amej
29 Jul 22
Prospectus supplement for primary offering
5:09pm
424B5
fu5i9eu5rd8x7euxij0x
14 Jun 22
Prospectus supplement for primary offering
5:19pm
424B5
umvdfxrf
14 Jun 22
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.1
efcuyd
11 Mar 22
Bio-path Holdings Reports Full Year 2021 Financial Results
7:30am
8-K
EX-99.1
pec31yhuwgy
13 Dec 21
Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting
7:40am
8-K
q9ui8mma
13 Dec 21
Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting
7:40am
8-K
EX-99.1
s8o1eq8h06mta97w
12 Nov 21
Bio-Path Holdings Reports Third Quarter 2021 Financial Results
7:10am
8-K
EX-99.1
ku10sck5yafrm4h
4 Nov 21
Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting
12:00am
8-K
96s8neb
4 Nov 21
Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting
12:00am
8-K
EX-99.1
rmf5ksz7n2ub 3o
14 Aug 20
Bio-path Holdings Reports Second Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
8g7la0y0
29 May 20
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology
4:15pm
8-K
s9e0bguo1cc r5paa4d
29 May 20
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology
4:15pm
8-K
EX-99.1
udxz9w4ut 5g1
15 May 20
Bio-path Holdings Reports First Quarter 2020 Financial Results
7:10am
8-K
ex59 jim7ne0t
14 May 20
Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting
4:30pm